RB Global heads into its November earnings window with short sellers quietly rebuilding positions against a stock that has shed 4% in the past month and sits roughly 35% below the consensus analyst target.
The most striking tension this week is the gap between where the stock trades and where the Street thinks it should be. RBA closed at $83.36 on Tuesday, down 3.2% on the week, while the mean analyst price target — last updated September 13 — stands at $128.64, implying more than 50% upside. RBC Capital reiterated its Outperform rating and $152 target as recently as September 23, one of the most bullish reads on the Street. Barclays, which carries an Overweight, trimmed its target to $121 from $124 in July. Stephens & Co. sits at the cautious end with an Equal-Weight and a $96 target. The direction of travel among the bulls is clearly higher, but the stock has refused to follow.
Short interest tells a more nuanced story than the price action alone. Bears hold 8.1% of the free float — a meaningful position, not an extreme one — and that share has crept up roughly 4% over the past month even as it barely moved on the week. The lending market offers no evidence of a squeeze building: availability runs at 536%, meaning for every share already borrowed, more than five additional shares remain available. Borrowing costs are negligible at 0.59%, though they ticked up 15% on the week after collapsing two-thirds over the prior month. That August cost-to-borrow spike — which briefly reached 2.07% around August 24-25 — has fully unwound. The borrow market is loose and shorts face no friction.
Options are the one data point suggesting caution above the baseline. The put/call ratio has moved to 0.41, about 1.4 standard deviations above its 20-day average of 0.37 — elevated, though still well short of the 0.60 reading that marked the year's most defensive positioning. Puts are gaining ground relative to calls, mirroring the modest uptick in short interest, and the pattern began after September 18, when the PCR briefly dipped. Neither the options nor the lending data points to a crowded or panicked setup — more a slow accumulation of caution as the November 5 earnings date approaches.
The catalyst question is central. RBA's most recent earnings print, on August 4, produced a one-day drop of 14.8% and a five-day loss of 20.1% — a brutal reaction that has almost certainly shaped current positioning. The prior print, in August 2026, had a more measured first-day gain of 1.2% that quickly reversed to a 14.5% five-day loss. Bears appear to be pricing in the possibility of another miss; bulls at RBC and Raymond James — which upgraded to Strong Buy in June with a $145 target — are betting the August selloff was overdone. With the ORTEX short score running at 56.5, in the lower-medium range of the 0-100 scale, sentiment is cautious but not yet at an extreme.
On insider activity, two directors made modest open-market purchases in September. Director Deborah Stein bought 500 shares around $81 on September 9. Director Chloe Harford bought 1,200 shares at $83.74 on August 24, shortly before the August earnings drop. Neither purchase was made under a 10b5-1 plan. The net 90-day insider position is a modest net buy of 2,050 shares worth roughly $164,000 — a directional signal, but not a material one at this price level.
Institutional ownership is concentrated and broadly stable. Vanguard and BlackRock together hold above 17% between them, and EdgePoint Investment Group — which added 749,781 shares in the last reported quarter — now sits at 5.16% of shares outstanding. There are no activist 13D filers on the register; all large-stake holders filed on passive 13G forms, and Vanguard's earlier 13.6% stake was wound down to zero by March 2026, a shift worth noting in the context of the stock's year-to-date decline.
The November 5 earnings print is now the clearest near-term reference point — the question framing the setup is whether the business can deliver a quarter that resets expectations after two consecutive post-earnings drawdowns, or whether bears at 8.1% of float will find their thesis confirmed again.
See the live data behind this article on ORTEX.
Open RBA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
